AIDS News and Research

RSS

Study shows significant increase in survival rates of extremely pre-term babies

A new study co-authored by a University of Rochester Medical Center researcher has found that the survival rates of extremely pre-term babies has increased significantly in the past decade.

1 Apr 2022

Researchers discover a cell plasticity and inflammation driving druggable copper-signaling pathway

A new study identified mechanisms regulating immune cell plasticity to develop new therapeutics.

31 Mar 2022

Booster doses provide strong protection against hospitalization and death from COVID-19

Booster doses of mRNA vaccines provided strong protection against hospitalization and death from COVID-19 in Qatar, though breakthrough SARS-CoV-2 infections were greater for the omicron variant compared with the delta variant, according to a study by investigators at Weill Cornell Medicine—Qatar.

30 Mar 2022

Clinical trials for experimental HIV vaccines based on mRNA technology begin in United States

Scientists urge African leaders to demand fair licensing following clinical trials of an HIV vaccine candidate.

30 Mar 2022

Music program teaches deaf and hard-of-hearing children to better understand sounds

A 12-week music program is helping deaf and hard-of-hearing children learn to optimize their hearing aids and cochlear implants, by teaching them to better understand the sounds they detect.

30 Mar 2022

Chaperone-mediated autophagy needed to protect against atherosclerosis

Revving up a process that slows down as we age may protect against atherosclerosis, a major cause of heart attacks and strokes.

28 Mar 2022

SARS-CoV-2 virus may have lingering effects on peripheral nerves

Adding to a growing body of evidence that, for many, problems related to COVID-19 linger longer than the initial infection, researchers at Washington University School of Medicine in St. Louis have found that some people infected during the pandemic's early months experienced peripheral neuropathy - pain, tingling and numbness in the hands and feet - during and following their bouts with the virus.

25 Mar 2022

U of A researcher receives $436,642 from NIH to study effects of SARS-COV-2 on the aortic valve

The National Institute of Health awarded $436,642 to associate professor of biomedical engineering, Kartik Balachandran, to study the downstream effects of acute respiratory syndrome coronavirus 2 on the aortic valve.

24 Mar 2022

Short duration treatment effective in combating most childhood TB cases, study says

Short duration treatment — four months instead of the standard six — is as effective in combating most cases of childhood tuberculosis (TB), says a study carried out in India and some African countries.

24 Mar 2022

New therapy makes immunologically 'cold' tumors hot enough for immune attack

Pancreatic cancer is notoriously difficult to cure or even treat. Now, a new strategy devised by scientists at Albert Einstein College of Medicine has succeeded in making pancreatic tumors visible to the immune systems of mice and vulnerable to immune attack, reducing cancer metastases by 87%.

23 Mar 2022

New York Blood Center and Columbia University partner to advance the use of mRNA technology in HIV vaccine study

New York Blood Center’s Project ACHIEVE and Columbia University’s Columbia Research Unit are working in partnership for the New York City effort to advance the use of messenger ribonucleic acid (mRNA) technology in an HIV preventive vaccine study – HVTN 302.

23 Mar 2022

Texas Biomed and UAB partnership uncovers a new, potent antibody cocktail against all coronaviruses

As SARS-CoV-2 has continued to evolve and outsmart existing treatments, scientists have not let up looking for ever-more effective tools to keep people safe and successfully recover from COVID-19, and to prepare for future outbreaks.

18 Mar 2022

Excessive neuropeptide secretion in the lungs can lead to fluid buildup and poor oxygenation

COVID-19 has put a spotlight on the pulmonary and nervous systems, but there is still much to learn about how they interact. Researchers at University of California San Diego School of Medicine recently explored this relationship in the context of a childhood lung disease, but their findings may also apply to COVID-19 symptoms.

17 Mar 2022

Highly sensitive PCR test for COVID-19 receives FDA emergency use authorization

A new highly sensitive, easy-to-use test for COVID-19 that requires a single swab and 15 minutes has received emergency use authorization (EUA) status from the U.S. Food and Drug Administration (FDA).

16 Mar 2022

New insight into SARS-CoV-2 nsp14 protein opens door to new drugs

In a recent research paper currently available on bioRxiv* preprint server, scientists from the University of Oxford in the United Kingdom and the University of Auckland in New Zealand identified several structural specificities of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that may serve as viable starting points for the development and optimization of viral inhibitors against coronavirus disease 2019 (COVID-19) and other future threats.

16 Mar 2022

New way to deliver potential HIV vaccine using mRNA technology

Using mRNA technology like that in the COVID-19 vaccines, researchers have demonstrated a successful way to deliver a potential HIV vaccine, researchers at Duke Human Vaccine Institute report.

15 Mar 2022

High doses of antibiotic may safely and effectively treat TB meningitis

A Johns Hopkins Children's Center-led study in animals suggests that high doses of a widely used antibiotic called rifampin may safely treat and reduce the duration of treatment for the deadliest form of tuberculosis that affects the brain, potentially improving survival rates for patients and decreasing the likelihood of lasting adverse effects of the disease.

15 Mar 2022

‘An Arm and a Leg’: Need an expensive drug? Here’s what you need to know

Lillian Karabaic teaches personal finance to millennials through a podcast and community called Oh My Dollar! — and she needs an expensive drug to treat a chronic condition.

15 Mar 2022

New Phase 1 clinical trial of mRNA HIV vaccine enrolls first participant

The first 12 study participants have been enrolled in a new Phase 1 clinical trial using the messenger ribonucleic acid (mRNA) vaccine technology developed by Moderna.

14 Mar 2022

UC San Diego receives $38 million USAID grant to address gender equity and health issues

The U.S. Agency for International Development has funded a $38 million, five-year project led by the Center on Gender Equity and Health at University of California San Diego School of Medicine and Herbert Wertheim School of Public Health and Human Longevity Science.

14 Mar 2022

AIDS News and Research

Study shows significant increase in survival rates of extremely pre-term babies

Researchers discover a cell plasticity and inflammation driving druggable copper-signaling pathway

Booster doses provide strong protection against hospitalization and death from COVID-19

Clinical trials for experimental HIV vaccines based on mRNA technology begin in United States

Music program teaches deaf and hard-of-hearing children to better understand sounds

Chaperone-mediated autophagy needed to protect against atherosclerosis

SARS-CoV-2 virus may have lingering effects on peripheral nerves

U of A researcher receives $436,642 from NIH to study effects of SARS-COV-2 on the aortic valve

Short duration treatment effective in combating most childhood TB cases, study says

New therapy makes immunologically 'cold' tumors hot enough for immune attack

New York Blood Center and Columbia University partner to advance the use of mRNA technology in HIV vaccine study

Texas Biomed and UAB partnership uncovers a new, potent antibody cocktail against all coronaviruses

Excessive neuropeptide secretion in the lungs can lead to fluid buildup and poor oxygenation

Highly sensitive PCR test for COVID-19 receives FDA emergency use authorization

New insight into SARS-CoV-2 nsp14 protein opens door to new drugs

New way to deliver potential HIV vaccine using mRNA technology

High doses of antibiotic may safely and effectively treat TB meningitis

‘An Arm and a Leg’: Need an expensive drug? Here’s what you need to know

New Phase 1 clinical trial of mRNA HIV vaccine enrolls first participant

UC San Diego receives $38 million USAID grant to address gender equity and health issues

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News